OptimizeRx Stock

OptimizeRx Gross Margin

The Gross Margin of OptimizeRx (OPRX) as of Jul 26, 2026 is 63.30 %. In the previous year, Gross Margin was 64.45 % — a change of -1.79% (lower).

Gross Margin

63.30 %

YoY

-1.79%

Last updated:

Gross Margin of OptimizeRx is 2026 63.30 % . Gross Margin of OptimizeRx was 2025 64.45 % . It decreases by -1.79% lower compared to the previous year.

OptimizeRx's gross margin stands at 63.3%, up from 58.1% several years earlier.

Access this data via the Eulerpool API

OptimizeRx Stock analysis

What does OptimizeRx do? The OPTIMIZERx Corporation is an emerging US company that is pursuing a revolutionary approach to solving challenges in healthcare. The company was founded in 2006 and is headquartered in Rochester, Michigan. OPTIMIZERx initially started as a provider of discount incentives to improve medication management. They later developed an innovative E-Prescribing platform to ensure the quick and secure delivery of medications to patients. Their business model focuses on providing scalable platforms and services to simplify and improve patient data management and communication. OPTIMIZERx offers products such as eCoupon, SampleMD, OptimizeRx Digital Therapeutic Support, and OptimizeRx 360. These platforms and services are sold to pharmaceutical companies, doctors, patients, and pharmacies to help reduce costs and optimize business processes. The company is divided into different categories including E-Prescribing, Patient-Centered Support, Point-of-Care Services, and Channel and Content Management. Overall, OPTIMIZERx aims to improve healthcare services through innovative technology and has achieved significant milestones such as a strong customer base and sustainable financial foundation. OptimizeRx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OptimizeRx stock

Gross Margin of OptimizeRx is 63.30 % in 2026.

Access this data via the Eulerpool API

Margins — OptimizeRx

All Key Metrics — OptimizeRx